UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...

Published on UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...

A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...

Underlying causes of recurrent pneumonia in children have changed in the last decade, indicating a need for individualized diagnostic approaches.

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to ...

Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the ...

Johns Hopkins biomedical engineers Ishan Vatsaraj, Stanley Chun Ming Wu, and Jaemyung Shin have been awarded highly ...

For many women with early breast cancer, surgery is effective but life-altering. New five-year data from the National Institutes for Quantum Science and Technology (QST) suggest that a precisely ...

A prospective phase I/II clinical trial led by QST Hospital reports that carbon-ion radiotherapy achieved five-year local control and disease-free survival rates of 92%, with no grade ≥2 toxicities, ...

AI chip startup Etched.ai has reportedly raised $500 million in a funding round that was led by investment firm Stripes and ...

Report considers where investors should pivot next, the breakthrough themes steering the 2026 innovation wave.